{"id":"https://openalex.org/W2051491327","doi":"https://doi.org/10.1038/nrd3744","title":"Outlook for the next 5 years in drug innovation","display_name":"Outlook for the next 5 years in drug innovation","publication_year":2012,"publication_date":"2012-06-01","ids":{"openalex":"https://openalex.org/W2051491327","doi":"https://doi.org/10.1038/nrd3744","mag":"2051491327","pmid":"https://pubmed.ncbi.nlm.nih.gov/22653208"},"language":"en","primary_location":{"id":"doi:10.1038/nrd3744","doi":"https://doi.org/10.1038/nrd3744","is_oa":false,"landing_page_url":"https://doi.org/10.1038/nrd3744","pdf_url":null,"source":{"id":"https://openalex.org/S186543748","display_name":"Nature Reviews Drug Discovery","issn_l":"1474-1776","issn":["1474-1776","1474-1784"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nature Reviews Drug Discovery","raw_type":"journal-article"},"volume":null,"type":"other","is_traditional":false,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Roy Berggren","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I75380228","display_name":"McKinsey & Company (United States)","ror":"https://ror.org/01gmv5d77","country_code":"US","type":"company","lineage":["https://openalex.org/I75380228"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Roy Berggren","raw_affiliation_strings":["Roy Berggren is at McKinsey & Company, 55 East 52nd Street, 16th Floor, New York, 10022, USA.,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roy Berggren is at McKinsey & Company, 55 East 52nd Street, 16th Floor, New York, 10022, USA.,","institution_ids":["https://openalex.org/I75380228"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028824818","display_name":"Martin M\u00f8ller","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Martin M\u00f8ller","raw_affiliation_strings":["Martin M\u00f8ller is at McKinsey & Company, Ved Stranden 14, DK-1061 Copenhagen K, Denmark.,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Martin M\u00f8ller is at McKinsey & Company, Ved Stranden 14, DK-1061 Copenhagen K, Denmark.,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011061316","display_name":"Rachel Ann Moss","orcid":"https://orcid.org/0000-0003-4634-2367","observed_orcids":["https://orcid.org/0000-0003-4634-2367"]},"institutions":[{"id":"https://openalex.org/I4210112384","display_name":"McKinsey & Company (United Kingdom)","ror":"https://ror.org/01v7cer31","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210112384","https://openalex.org/I75380228"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Rachel Moss","raw_affiliation_strings":["Rachel Moss is at McKinsey & Company, No. 1 Jermyn Street, London SW1Y 4UH, UK.,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Rachel Moss is at McKinsey & Company, No. 1 Jermyn Street, London SW1Y 4UH, UK.,","institution_ids":["https://openalex.org/I4210112384"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014138818","display_name":"Pawel Poda","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I75380228","display_name":"McKinsey & Company (United States)","ror":"https://ror.org/01gmv5d77","country_code":"US","type":"company","lineage":["https://openalex.org/I75380228"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pawel Poda","raw_affiliation_strings":["Pawel Poda and Katarzyna Smietana are at McKinsey & Company, Plac Grunwaldzki 23, Wroclaw 50-365, Poland.,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pawel Poda and Katarzyna Smietana are at McKinsey & Company, Plac Grunwaldzki 23, Wroclaw 50-365, Poland.,","institution_ids":["https://openalex.org/I75380228"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5041732463","display_name":"Katarzyna \u015amietana","orcid":"https://orcid.org/0000-0002-6745-6294","observed_orcids":["https://orcid.org/0000-0002-6745-6294"]},"institutions":[{"id":"https://openalex.org/I75380228","display_name":"McKinsey & Company (United States)","ror":"https://ror.org/01gmv5d77","country_code":"US","type":"company","lineage":["https://openalex.org/I75380228"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Katarzyna Smietana","raw_affiliation_strings":["Pawel Poda and Katarzyna Smietana are at McKinsey & Company, Plac Grunwaldzki 23, Wroclaw 50-365, Poland.,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pawel Poda and Katarzyna Smietana are at McKinsey & Company, Plac Grunwaldzki 23, Wroclaw 50-365, Poland.,","institution_ids":["https://openalex.org/I75380228"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5028824818"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":55,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"11","issue":"6","first_page":"435","last_page":"436"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11649","display_name":"Pharmaceutical industry and healthcare","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2910","display_name":"Issues, ethics and legal aspects"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12851","display_name":"Firm Innovation and Growth","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pharmaceutical-innovation","display_name":"pharmaceutical innovation","score":0.9679999947547913},{"id":"https://openalex.org/keywords/new-drug-approvals","display_name":"new drug approvals","score":0.8190000057220459},{"id":"https://openalex.org/keywords/drug-pipeline","display_name":"drug development pipeline","score":0.675000011920929},{"id":"https://openalex.org/keywords/revenue-forecasts","display_name":"revenue forecasts","score":0.6700000166893005},{"id":"https://openalex.org/keywords/pharmaceutical-industry-trends","display_name":"pharmaceutical industry trends","score":0.7229999899864197},{"id":"https://openalex.org/keywords/drug-discovery","display_name":"drug discovery","score":0.45399999618530273}],"concepts":[{"id":"https://openalex.org/C195487862","wikidata":"https://www.wikidata.org/wiki/Q850210","display_name":"Revenue","level":2,"score":0.6747099161148071},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.6140773892402649},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.5875248312950134},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.534397542476654},{"id":"https://openalex.org/C43521106","wikidata":"https://www.wikidata.org/wiki/Q2165493","display_name":"Pipeline (software)","level":2,"score":0.5236075520515442},{"id":"https://openalex.org/C2992293740","wikidata":"https://www.wikidata.org/wiki/Q4781752","display_name":"Drug approval","level":3,"score":0.504635214805603},{"id":"https://openalex.org/C2993777677","wikidata":"https://www.wikidata.org/wiki/Q507443","display_name":"Drug industry","level":2,"score":0.4952756464481354},{"id":"https://openalex.org/C192209626","wikidata":"https://www.wikidata.org/wiki/Q190909","display_name":"Focus (optics)","level":2,"score":0.4485810101032257},{"id":"https://openalex.org/C2777494893","wikidata":"https://www.wikidata.org/wiki/Q4781752","display_name":"Approved drug","level":3,"score":0.4331004023551941},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.3658933639526367},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3040967881679535},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.29472875595092773},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.2335738241672516},{"id":"https://openalex.org/C10138342","wikidata":"https://www.wikidata.org/wiki/Q43015","display_name":"Finance","level":1,"score":0.17483773827552795},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.15363991260528564},{"id":"https://openalex.org/C55587333","wikidata":"https://www.wikidata.org/wiki/Q1133029","display_name":"Engineering ethics","level":1,"score":0.09438446164131165},{"id":"https://openalex.org/C199360897","wikidata":"https://www.wikidata.org/wiki/Q9143","display_name":"Programming language","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C120665830","wikidata":"https://www.wikidata.org/wiki/Q14620","display_name":"Optics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001688","descriptor_name":"Biological Products","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004059","descriptor_name":"Diffusion of Innovation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004345","descriptor_name":"Drug Industry","qualifier_ui":"Q000639","qualifier_name":"trends","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017850","descriptor_name":"Economics, Pharmaceutical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D054852","descriptor_name":"Small Molecule Libraries","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055808","descriptor_name":"Drug Discovery","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D055808","descriptor_name":"Drug Discovery","qualifier_ui":"Q000639","qualifier_name":"trends","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1038/nrd3744","doi":"https://doi.org/10.1038/nrd3744","is_oa":false,"landing_page_url":"https://doi.org/10.1038/nrd3744","pdf_url":null,"source":{"id":"https://openalex.org/S186543748","display_name":"Nature Reviews Drug Discovery","issn_l":"1474-1776","issn":["1474-1776","1474-1784"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nature Reviews Drug Discovery","raw_type":"journal-article"},{"id":"pmid:22653208","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22653208","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nature reviews. Drug discovery","raw_type":"News"}],"best_oa_location":null,"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":2,"referenced_works":["https://openalex.org/W2029149156","https://openalex.org/W2166550586"],"related_works":["https://openalex.org/W4239250108","https://openalex.org/W4241246022","https://openalex.org/W4406394337","https://openalex.org/W7127037806","https://openalex.org/W2914545891","https://openalex.org/W7134912955","https://openalex.org/W2925973376","https://openalex.org/W3030954656","https://openalex.org/W2913780258","https://openalex.org/W3130309548"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":8},{"year":2015,"cited_by_count":7},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":5}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}